| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 |
| P795345 | MACKLIN | 普里米酮 | 10mM in DMSO | 350元/1ml; | 展开 |
|
| P838250 | MACKLIN | 普里米酮 | 98% | 30元/100mg; 80元/500mg; 152元/5g; 405元/25g; 1410元/100g; | 展开 |
|
| P1906 | TCI | Primidone | >98.0%(HPLC)(N) | 325元/5G; 935元/25G; | 展开 |
基本信息 | 纯度/分析方法 | >98.0%(HPLC)(N) | | 分子式/分子量 | C12H14N2O2 = 218.26 | | 外观与形状(20℃) | 固体 | | Reaxys-RN | 218034 | | PubChem物质ID | 125307742 | | Merck Index (14) | 7746 | | MDL编号 | MFCD00038662 |
技术规格 | Appearance | White to Almost white powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(with Total Nitrogen) | min. 98.0 % |
物性(参考值) | 熔点 | 281 ℃ | | 水溶性 | 不溶 | | 溶解性(可溶于) | 二甲基甲酰胺 | | 溶解度(极微溶) | 乙醇 | | 溶解性(不溶于) | 乙醚 |
安全信息 | 图形或危害标志 |   | | 信号词 | 警告 | | 危险性说明 | H302 : 吞咽有害。 H351 : 怀疑致癌。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。 P270 : 使用本产品时不要进食、饮水或吸烟。 P202 : 在阅读并明了所有安全措施前切勿搬动。 P201 : 使用前取得专用说明。 P264 : 作业后彻底清洗皮肤。 P280 : 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P308 + P313 : 如接触到或有疑虑:求医/就诊。 P301 + P312 + P330 : 如误吞咽:如感觉不适,呼叫急救中心/医生。漱口。 P405 : 存放处须加锁。
|
相关法规 |
| 179837 | J&K | Primidone | 99%, 一种GABA受体抑制剂 | 280元/5G; 808元/25G; | 展开 |
基本信息 | 分子式 | C12H14N2O2 | | 分子量 | 218.25 | | MDL编码 | MFCD00038662 | | Beilstein | 218034 | | Merck | 14,7746 | | EINECS 编号 | 204-737-0 | 产品描述 Primidone 是一种嘧啶二酮类抗惊厥药。 靶点(IC50 & Targe) GABAR GluR2 nAChR Sodium Channel 安全信息 | 图形或危害标志 |   | | 提示语 | Warning | | 危险说明 | H302 H351 | | 防范说明 | P281 | | WGK | 3 | | RTECS | UV9100000 |
|
| P2950000 | | Primidone | European Pharmacopoeia (EP) Reference Standard | 1259.15元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 150 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C12H14N2O2 | | 分子量 | 218.25 | | MDL编号 | MFCD00038662 | | PubChem化学物质编号 | 329820157 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | CCC1(C(=O)NCNC1=O)c2ccccc2 | | InChI | 1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16) | | InChI key | DQMZLTXERSFNPB-UHFFFAOYSA-N | | Gene Information | human ... GABRA1(2554), GABRA2(2555), GABRA3(2556), GABRA4(2557), GABRA5(2558), GABRA6(2559), GABRB1(2560), GABRB2(2561), GABRB3(2562), GABRD(2563), GABRE(2564), GABRG1(2565), GABRG2(2566), GABRG3(2567), GABRP(2568), GABRQ(55879), SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335) |
安全信息 | 象形图 |   | | 警示用语: | Warning | | 危险声明 | H302 - H351 - H361d | | 预防措施声明 | P201 - P202 - P264 - P270 - P301 + P312 - P308 + P313 | | 危险分类 | Acute Tox. 4 Oral - Carc. 2 - Repr. 2 | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| P7295 | Supelco | Primidone | analytical standard | 794.5元/5 G; | 展开 |
产品说明 一般描述 Primidone is a commonly used antiepileptic and anticonvulsant drug belonging to the class of barbiturates. It is found to be effective in the treatment of partial and generalized seizures. 应用 Primidone may be used as a reference standard for the determination of the analyte in serum samples using high-pressure liquid chromatography. Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support. 包装 5 g in glass bottle 生化/生理作用 抗惊厥药 其他说明 Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. P7295.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin. 基本信息 | 经验(实验)分子式 | C12H14N2O2 | | 分子量 | 218.25 | | EC 号 | 204-737-0 | | MDL编号 | MFCD00038662 | | PubChem化学物质编号 | 329820263 | | NACRES | NA.24 |
产品性质 | 等级 | analytical standard | | 质量水平 | 100 | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | application(s) | forensics and toxicology pharmaceutical (small molecule) veterinary | | 格式 | neat | | SMILES string | CCC1(C(=O)NCNC1=O)c2ccccc2 | | InChI | 1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16) | | InChI key | DQMZLTXERSFNPB-UHFFFAOYSA-N | | Gene Information | human ... GABRA1(2554), GABRA2(2555), GABRA3(2556), GABRA4(2557), GABRA5(2558), GABRA6(2559), GABRB1(2560), GABRB2(2561), GABRB3(2562), GABRD(2563), GABRE(2564), GABRG1(2565), GABRG2(2566), GABRG3(2567), GABRP(2568), GABRQ(55879), SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335) |
安全信息 | 象形图 |   | | 警示用语: | Warning | | 危险声明 | H302 - H351 - H361d | | 预防措施声明 | P201 - P202 - P264 - P270 - P301 + P312 - P308 + P313 | | 危险分类 | Acute Tox. 4 Oral - Carc. 2 - Repr. 2 | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | Eyeshields, Gloves, type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges |
|
| Y0002215 | | Primidone for system suitability | CRS European Pharmacopoeia (EP) Reference Standard | 1295.6元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C12H14N2O2 | | 分子量 | 218.25 | | MDL编号 | MFCD00038662 |
产品性质 | 储存温度 | 2-8℃ | | SMILES string | CCC1(C(=O)NCNC1=O)c2ccccc2 | | InChI | 1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16) | | InChI key | DQMZLTXERSFNPB-UHFFFAOYSA-N |
安全信息 | 象形图 |   | | 警示用语: | Warning | | 危险声明 | H302 - H351 - H361d | | 预防措施声明 | P201 - P202 - P264 - P270 - P301 + P312 - P308 + P313 | | 危险分类 | Acute Tox. 4 Oral - Carc. 2 - Repr. 2 | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| PHR3109 | Supelco | Primidone | pharmaceutical secondary standard, certified reference material | 2317.45元/500 mg; | 展开 |
产品说明 一般描述 Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards 分析说明 These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAA6959(changes by product) in the Documents slot below. This is an example certificate only and may not be the lot that you receive. 基本信息 | 经验(实验)分子式 | C12H14N2O2 | | 分子量 | 218.25 | | MDL编号 | MFCD00038662 |
产品性质 | 等级 | certified reference material pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | 包装 | pkg of 500 mg | | application(s) | pharmaceutical | | 药典可追溯性 | traceable to USP 1562000 | | 储存温度 | 2-30℃ | | SMILES string | CCC1(C(=O)NCNC1=O)c2ccccc2 | | InChI | 1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16) | | InChI key | DQMZLTXERSFNPB-UHFFFAOYSA-N |
安全信息 | 象形图 |   | | 警示用语: | Warning | | 危险声明 | H302 - H351 - H361d | | 预防措施声明 | P201 - P202 - P264 - P270 - P301 + P312 - P308 + P313 | | 危险分类 | Acute Tox. 4 Oral - Carc. 2 - Repr. 2 | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1562000 | USP | Primidone | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C12H14N2O2 | | 分子量 | 218.25 | | MDL编号 | MFCD00038662 | | PubChem化学物质编号 | 329750946 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | CCC1(C(=O)NCNC1=O)c2ccccc2 | | InChI | 1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16) | | InChI key | DQMZLTXERSFNPB-UHFFFAOYSA-N | | Gene Information | human ... GABRA1(2554), GABRA2(2555), GABRA3(2556), GABRA4(2557), GABRA5(2558), GABRA6(2559), GABRB1(2560), GABRB2(2561), GABRB3(2562), GABRD(2563), GABRE(2564), GABRG1(2565), GABRG2(2566), GABRG3(2567), GABRP(2568), GABRQ(55879), SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335) |
安全信息 | 象形图 |   | | 警示用语: | Warning | | 危险声明 | H302 - H351 - H361d | | 预防措施声明 | P201 - P202 - P264 - P270 - P301 + P312 - P308 + P313 | | 危险分类 | Acute Tox. 4 Oral - Carc. 2 - Repr. 2 | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP293 | | Primidone | British Pharmacopoeia (BP) Reference Standard | 2144.18元/100 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C12H14N2O2 | | 分子量 | 218.25 | | EC 号 | 204-737-0 | | MDL编号 | MFCD00038662 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | CCC1(C(=O)NCNC1=O)c2ccccc2 | | InChI | 1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16) | | InChI key | DQMZLTXERSFNPB-UHFFFAOYSA-N | | Gene Information | human ... GABRA1(2554), GABRA2(2555), GABRA3(2556), GABRA4(2557), GABRA5(2558), GABRA6(2559), GABRB1(2560), GABRB2(2561), GABRB3(2562), GABRD(2563), GABRE(2564), GABRG1(2565), GABRG2(2566), GABRG3(2567), GABRP(2568), GABRQ(55879), SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335) |
安全信息 | 象形图 |   | | 警示用语: | Warning | | 危险声明 | H302 - H351 - H361d | | 预防措施声明 | P201 - P202 - P264 - P270 - P301 + P312 - P308 + P313 | | 危险分类 | Acute Tox. 4 Oral - Carc. 2 - Repr. 2 | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|